To investigate the infectivity of hepatitis B virus (HBV) from mothers to their newborn offspring, HBV-DNA in Although the infectivity of HBV is conventionally monitored by noting the presence of HBeAg and by measuring the activity of HBV specific DNA polymerase, recent advances in molecular hybridisation technology have provided more sensitive markers of HBV infection.4 5 HBV-DNA can be detected even in anti-HBe positive sera,6 and regardless of HBeAg status, the quantity of circulating HBV-DNA is directly related to HBV infectivity and to the activity of chronic liver disease.7 8 However, any mechanisms of HBV transmission from HBeAg negative, HBsAg positive carrier mothers to their babies have never been documented.
Since the establishment of the national project for prevention of mother to infant transmission of hepatitis B virus (HBV) with hepatitis B immunoglobulin (HBIg) and HBV vaccine, approximately 90-95% of the offspring of hepatitis Be antigen (HBeAg) positive HBV carrier mothers acquired protection from perinatal infection in Japan.1 2 In contrast, prophylaxis is not recommended for infants of HBeAg negative mothers, who comprise three quarters of pregnant hepatitis B carriers. About 10% of infants born to such mothers are reported to develop acute or fulminant hepatitis.3 As half of the cases of infantile fulminant hepatitis are due to perinatal HBV infection, and because most mothers of these patients are HBeAg negative, hepatitis B surface antigen (HBsAg) positive carriers,3 protective measures for these infants are urgently needed.
Although the infectivity of HBV is conventionally monitored by noting the presence of HBeAg and by measuring the activity of HBV specific DNA polymerase, recent advances in molecular hybridisation technology have provided more sensitive markers of HBV infection.4 5 HBV-DNA can be detected even in anti-HBe positive sera, 6 and regardless of HBeAg status, the quantity of circulating HBV-DNA is directly related to HBV infectivity and to the activity of chronic liver disease.7 8 However, any mechanisms of HBV transmission from HBeAg negative, HBsAg positive carrier mothers to their babies have never been documented.
In the present study, to explore the infectivity of anti-HBe positive, HBsAg positive carrier mothers to their offspring the expression of HBV-DNA was determined in plasma and peripheral mononuclear cells by a newly developed method, the polymerase chain reaction. Coupled with molecular hybridisation analysis the polymerase chain reaction can define attogram concentrations of HBV-DNA.9 The present results demonstrate the close association between the HBV-DNA expression in maternal peripheral mononuclear cells and the onset of acute or fulminant hepatitis in early infancy.
Subjects and methods
The serological markers of HBV infection were detected by reverse passive haemagglutination for HBsAg, passive haemagglutination for antiHBs, immunoadherence haemagglutination for antibody to hepatitis B core antigen, and enzyme linked immunosorbent assay for HBeAg and its antibody (Abbott Laboratories).
We examined 28 mothers known to be antiHBe positive, HBsAg positive carriers and 29 of their infants. The mothers were asymptomatic, without liver function abnormalities, during a one to five year follow up. All infants studied were negative for HBsAg and anti-HBs in cord blood, and serum HBsAg and anti-HBs concentrations and transaminase activities were measured every three months until age 1 year. At birth and at 2 months of age two infants were given HBIgs 5'-ACAGAGTCTAGACTCGTGGT-3', primer 5 86R: 5 '-AAAGCCCTACGAACCACTGA-3'), 50 mmol/ml potassium chloride, 10 mmol/l TRIS-hydrochloric acid (pH8-3), 1-5 mmol/l magnesium chloride, and 0 01% gelatin. Ampli HBeAg negative and anti-HBe positive, and none showed evidence of active hepatitis. During the next one to five years, serological markers and transaminase activities of these women were essentially unchanged. The HBV infection status of each father was also determined, and no evidence of infection was obtained (data not shown).
DNA was extracted from 200 1d of plasma and 106 mononuclear cells of the mothers categorised as above. Each DNA was amplified by 25 cycles of the polymerase chain reaction. A sample was regarded as positive when DNA with a molecular weight expected for the amplified product (473 base pairs) was seen in agarose/Nusieve gel in three independent experiments. Southern hybridisation was used to confirm the specificity of the amplified DNA.
All of the 28 plasma samples were negative by both direct visualisation of amplified DNA and by Southern hybridisation, even when increased amounts of DNA were applied in the polymerase chain reaction mixture. In contrast, 473 base pair bands were detected in three of 28 mononuclear cell DNA samples (fig 1) . The HBV specificity of these amplified DNAs was con- firmed by Southern hybridisation (fig 2) . The remaining 25 mononuclear cell DNA samples were negative by both DNA gel analysis and hybridisation (partly shown in figs 1 and 2). The HBV markers and transaminase activities of the offspring were serially determined. Among the four infants born to the three mothers who carried HBV-DNA positive mononuclear cells, two developed acute or fulminant hepatitis within three months after birth (table). In the infant with acute hepatitis antiHBs, and later anti-HBc, became positive, confirming HBV infection. One of the remaining two infants, who was the younger sister of the girl who died from fulminant hepatitis, was administered HBIg/HBV vaccine, and acquired protection against HBV as her anti-HBs was positive and anti-HBc negative after prophylaxis. The last one of the four was also administered HBIg/HBV vaccine because her mother seroconverted from HBeAg positive to antiHBe positive shortly before delivery (between 29 and 36 weeks of gestation), and the infant also acquired HBV protection (table). In the other 25 infants, whose mothers were HBV-DNA negative in both plasma and mononuclear cells, no HBV markers and no increased activities of transaminases were detected in the next seven months to 3* 5 years. Taken together these results strongly suggests that the association between the HBV-DNA expression in maternal peripheral mononuclear cells and the HBV infection of their infants is highly specific.
Discussion
The present study demonstrates that even asymptomatic, anti-HBe positive pregnant women may carry HBV-DNA positive mononuclear cells in the peripheral blood that can transmit infectious HBV to their offspring. This is the first report concerning the association between the presence of HBV-DNA in maternal mononuclear cells and the onset of infantile hepatitis. In Japan 1-2% of pregnant women are HBsAg positive carriers and three quarters of them are HBeAg negative. This percentage of HBV carriers seems relatively high, but the prevalence of HBV in Japan is about 20 times more than in Europe. Therefore it is important to pick up high risk infants and to find the most effective means of treatment. Our findings indicate that HBV determination in peripheral mononuclear cells of such pregnant women will aid screening of high risk infants before delivery.
Infectivity of HBV was apparently due to mononuclear cells in matemal peripheral blood. In order to acquire the capability of viral replication, the infected mononuclear cells are probably transmitted first as intact cells to the infants, and then the HBV is activated. The possible route of mononuclear cell transmission could be transplacental passage around delivery. Previously, Desai and Creger reported that the maternal mononuclear cells definitely circulate in newborn babies. 0 They labelled in vitro the maternal peripheral mononuclear cells by immunofluorescence and injected them back into the mother shortly before delivery. They detected the labelled matemal mononuclear cells in the infant's circulation. Very recently the transfer of mononuclear cells from fetus to mother was determined by the polymerase chain reaction. Y chromosome specific DNA sequences were detected in pregnant women carrying male fetuses. " These findings strongly suggested that bidirectional mononuclear cell traffic between mother and fetus is not uncommon. Therefore, it is most likely that HBV carrying maternal mononuclear cells traverse the placenta intact. But other routes of HBV transmission, for example horizontal infection after birth, are possible. Further studies are needed.
It was surprising that, though the women were asymptomatic, acute or fulminant hepatitis could occur in the infants. The HBs antigenaemia in these anti-HBe positive women might at least indicate active translation of viral DNA, which is the final step of HBV expression, suggesting that an immunological inactivation process is operating in the women. Such a mechanism might be too immature and thus unable to protect the infants from viral activation. Urinary infection: what little boys do in the bath A recent paper from Quebec (J Labbe, Pediatrics 1990;86:703-6) raises an interesting new possibility as regards the aetiology of urinary infection in boys. A prospective consecutive series of 22 boys aged between 5 and 15 years who attended a urinary infection clinic at a university medical centre, together with nine others detected retrospectively, were questioned about penile self instrumentation in the bath or shower. Ten of the 31 admitted injecting bath water into the urethra in the few days before the onset of symptoms. The instruments used were a syringe (n=4), a rubber bulb (n=3), a plastic bottle (n=2), and a 'hand-held shower massager' (n= 1). Lower abdominal pain, dysuria, and gross haematuria were more common in the 10 boys who admitted self instrumentation (group A) than in the 21 who didn't (group B). Urine culture in group A produced Escherichia coli in five and Staphylococcus saprophyticus in the other five. Only one child in group B was infected with the latter organism. Imaging of the renal tracts showed no abnormalities in group A but was abnormal in a third of the boys in group B. Is this study representative? I imagine, but don't know, that such things as syringes and rubber bulbs may be less available in British bathrooms. The frequency of this behaviour in normal boys is unknown so it is difficult to assess the size of its contribution, if any, to the problem of urinary infection in boys, but it's an idea worth pursuing. No doubt we shall hear more on this subject.
